Cargando...
Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines
Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which is hypothesized to regulate cell cycle progression in tumor cells. However, whether CDKN3 is a potential therapeutic target for breast cancer remains to be elucidated. The present in vitro s...
Gardado en:
| Publicado en: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940103/ https://ncbi.nlm.nih.gov/pubmed/27314680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2016.5401 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|